Saxagliptin
Links shared publicly online about this topic
Saxagliptin approved for diabetic patients
theheart.org — “The FDA has approved once-daily saxagliptin tablets for use with diet and exercise to control hyperglycemia in patients with type2 diabetes mellitus.” View full resource at theheart.org
Most Recently Shared on August 3, 2009 at 5:44 pm By:
heartwire: Saxagliptin approved to improve glycemic control in diabetic patients http://bit.ly/WoT7T
FDA Approves Onglyza (saxagliptin) for Type 2 Diabetes
drugs.com — “Onglyza (saxagliptin) is used to treat Type 2 diabetes. Includes Onglyza side effects, interactions and indications.” View full resource at drugs.com
Most Recently Shared on August 1, 2009 at 3:03 am By:
FDA Approves Onglyza (saxagliptin) for Type 2 Diabetes - http://bit.ly/19lKrd
European Commission Extends Licence For ONGLYZATM (Saxagliptin)
medicalnewstoday.com — “The European Commission has granted a licence extension for Bristol-Myers Squibb and AstraZeneca's oral antidiabetic ONGLYZATM (saxagliptin) to include Type 2 diabetes patients with moderate or se” View full resource at medicalnewstoday.com
Most Recently Shared on March 6, 2011 at 8:05 am By:
European Commission Extends Licence For ONGLYZATM (Saxagliptin) http://mnt.to/3RTT #urology
European Commission Extends Licence For ONGLYZATM (Saxagliptin)
medicalnewstoday.com — “The European Commission has granted a licence extension for Bristol-Myers Squibb and AstraZeneca's oral antidiabetic ONGLYZATM (saxagliptin) to include Type 2 diabetes patients with moderate or se” View full resource at medicalnewstoday.com
Most Recently Shared on March 6, 2011 at 10:41 am By:
Urology & Nephrology OW Health
European Commission Extends Licence For ONGLYZATM (Saxagliptin): The European Commission has granted a licence e... http://bit.ly/hjhL5U
European Commission Extends Licence For ONGLYZATM (Saxagliptin)
medicalnewstoday.com — “The European Commission has granted a licence extension for Bristol-Myers Squibb and AstraZeneca's oral antidiabetic ONGLYZATM (saxagliptin) to include Type 2 diabetes patients with moderate or se” View full resource at medicalnewstoday.com
Most Recently Shared on March 7, 2011 at 2:56 am By:
European Commission Extends Licence For ONGLYZATM (Saxagliptin): The European Commission has granted a licence e... http://bit.ly/i6QQaQ
FDA approved saxagliptin to treat type 2 diabetes
endocrinetoday.com — “Patients with type 2 diabetes now have a new treatment option: saxagliptin, a dipeptidyl peptidase-4 inhibitor that stimulates the pancreas to c” View full resource at endocrinetoday.com
Most Recently Shared on July 31, 2009 at 7:04 pm By:
Read more about the just-approved #diabetes drug, #saxagliptin: http://tinyurl.com/nw355h
ONGLYZA™ (saxagliptin) Launched In The UK For The Treatment Of Type 2 Diabetes
medicalnewstoday.com — “Bristol-myers squibb company and astrazeneca announced the launch of onglyza™ (saxagliptin) in the uk for the treatment of type 2 diabetes in adults, as add-on therapy with metformin, a thia” View full resource at medicalnewstoday.com
Most Recently Shared on October 16, 2009 at 3:31 pm By:
ONGLYZA™ (saxagliptin) Launched In The UK For The Treatment Of Type 2 Diabetes: Bristol-Myers Squibb Comp.. http://bit.ly/4y6x0f
Saxagliptin (Onglyza) Approved for Diabetes Approved by FDA - Health Blog - WSJ
blogs.wsj.com — “The FDA approved a new diabetes drug in a class Merck has had to itself since 2006.” View full resource at blogs.wsj.com
Most Recently Shared on July 31, 2009 at 7:45 pm By:
Saxagliptin Approval: Finally, Competition for Merck’s Januvia http://bit.ly/11UCBy
Saxagliptin (Onglyza) Approved for Diabetes Approved by FDA - Health Blog - WSJ
blogs.wsj.com — “The FDA approved a new diabetes drug in a class Merck has had to itself since 2006.” View full resource at blogs.wsj.com
Most Recently Shared on July 31, 2009 at 8:03 pm By:
Leigh Ann Otte Health Magazine
FDA approves new type-2 diabetes drug: http://snurl.com/of70n (@WSJHealthBlog)
FDA approves metformin/saxagliptin combination for type 2 diabetes
endocrinetoday.com — “The once-daily metformin extended-release plus dipeptidyl peptidase-4 tablet demonstrated significant reductions in HbA1c levels, fasting plasma” View full resource at endocrinetoday.com
Most Recently Shared on November 8, 2010 at 4:36 pm By:
#FDA approves metformin/saxagliptin combination for type 2 diabetes http://bit.ly/aJUY00
New Diabetes Drugs Alogliptin, Saxagliptin Show Promise in Studies
diabetes.webmd.com — “Two new drugs, alogliptin and saxagliptin, show promise at treating type 2 diabetes, researchers report.” View full resource at diabetes.webmd.com
Most Recently Shared on September 9, 2008 at 6:29 pm By:
WebMD Health News 2 New Drugs May Help Fight Diabetes: Two new drugs, alogliptin and .. http://tinyurl.com/5vlsqz
Clinical overview of saxagliptin for Type 2 diabetes management http://hub.am/frbpbh
blog.mdlinx.com — “Clinical overview of saxagliptin for Type 2 diabetes management http://hub.am/frbpbh” View full resource at blog.mdlinx.com
Most Recently Shared on December 6, 2010 at 2:06 pm By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Clinical overview of saxagliptin for Type 2 diabetes management http://hub.am/frbpbh
IngentaConnect Saxagliptin: a guide to its use in type 2 diabetes mellitus
ingentaconnect.com — “IngentaConnect Saxagliptin: a guide to its use in type 2 diabetes mellitus” View full resource at ingentaconnect.com
Most Recently Shared on July 8, 2010 at 10:46 am By:
Saxagliptin: a guide to its use in type 2 diabetes mellitus: (Source: Drugs) http://bit.ly/bQY3Ri
Family Med Medical News about Diabetes Mellitus, Type 2 Cardiovascular System Saxagliptin
mdlinx.com — “A Systematic Assessment of Cardiovascular Outcomes in the Saxagliptin Drug Development Program for Type 2 Diabetes” View full resource at mdlinx.com
Most Recently Shared on May 18, 2010 at 10:56 am By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
A Systematic Assessment of Cardiovascular Outcomes in the Saxagliptin Drug Development Program for Type... http://bit.ly/9XBWjj #GM #mdlinx
MedWire News - Diabetes - Saxagliptin non-inferior to glipizide in Type 2 diabetes
medwire-news.md — “MedWire News For patients with Type 2 diabetes who show inadequate glycemic control on metformin alone, add-on therapy with saxagliptin achieves equivalent reductions in glycated hemoglobin as standard glipizide, results of a non-inferiority trial show. MedWire News” View full resource at medwire-news.md
Most Recently Shared on October 12, 2010 at 9:22 pm By:
Endocrinology Wisdom OW Health
Saxagliptin non-inferior to glipizide in Type 2 diabetes: For patients with Type 2 diabetes who show inadequate gl... http://bit.ly/bMxJb6
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Related Health Centers
Featuring the top 3 experts for this topic
-
Shelley Wood
Managing editor for heartwire on theheart.org--the most authoritative, balanced, and insightful cardiovascular disease news online. http://is.gd/nHJ4
-
Drugs.com
Keeping you up to date with the latest medication news, FDA Medwatch alerts and new drug approvals.
-
MNT Urology
The latest urology/nephrology news published daily. Articles from research centers, universities and prestigious journals.
Advertisement
